The Transcription Factor TFIIIB Complex: A Promising Drug Target and Biomarker

Target Name: Transcription factor TFIIIB complex

NCBI ID: P22705

Transcription factor TFIIIB complex

Other Name(s): None

The Transcription Factor TFIIIB Complex: A Promising Drug Target and Biomarker

Introduction

The transcription factor TFIIIB (Transcription Factor IIB) complex plays a key role in gene expression and regulation. TFIIIB is a protein complex composed of multiple subunits and is mainly involved in regulating gene expression, including transcription initiation, RNA binding, and transcription termination. Abnormal expression of TFIIIB is closely related to various diseases such as cancer and neurodegenerative diseases. Therefore, studying the biological functions and drug targets of TFIIIB has important theoretical and practical value.

Biological functions of TFIIIB

TFIIIB plays an important role in the regulation of gene expression, mainly in the following aspects:

1. Transcription initiation: TFIIIB participates in the recognition and formation of the RNA polymerase (RNA polymerase, RNA-pol) binding site (DNA-protein interface, DNA-RNA binding), thereby participating in the initiation of gene transcription. The 伪 subunit of TFIIIB binds to DNA to form a hybrid double-stranded structure, provides a binding site for RNA-pol, and participates in the promoter recognition and binding of RNA-pol.

2. RNA binding: The 尾 and 纬 subunits in TFIIIB have RNA-binding activity and can bind to different types of RNA, including mRNA, rRNA, tRNA, etc. These binding events provide stability to gene expression and regulation.

3. Transcription termination: The 尾 subunit of TFIIIB participates in the termination process of RNA-pol, including the dissociation of the RNA-pol binding site and the release of the RNA chain.

4. Epigenetics: The DNA-protein binding site of TFIIIB can undergo DNA methylation modification, affecting gene expression. Methylation modifications can affect gene transcription by changing the stability of TFIIIB through binding protein recruitment.

Drug targets for TFIIIB

TFIIIB plays an important role in tumorigenesis, neurodegenerative diseases and other diseases, and is therefore considered a potential drug target. Currently, researchers have discovered TFIIIB-related genes and signaling pathways in multiple cancer types. These findings provide an important theoretical basis for the development of anti-TFIIIB drugs.

1. Research on anti-tumor drugs: Drug research on TFIIIB mainly focuses on inhibiting the activity of TFIIIB, reducing the binding affinity of TFIIIB to RNA, and blocking the binding of TFIIIB to DNA. These drugs include inhibitors, small molecule RNA (SMRNA) antagonists and binders. These drugs can inhibit the growth and spread of tumor cells by interfering with the biological functions of TFIIIB.

2. Research on neurodegenerative diseases: TFIIIB plays an important role in neurodegenerative diseases, so drug research on TFIIIB mainly focuses on interfering with the role of TFIIIB in neurodegenerative diseases, including improving cognition in patients with neurodegenerative diseases. Function, reduce symptoms of neurodegenerative diseases, etc.

3. Research on inflammation and immune regulation: TFIIIB plays a role in inflammation and immune regulation. Therefore, drug research on TFIIIB mainly focuses on intervening inflammation and immune response, including inhibiting inflammatory response, promoting immune response, etc.

in conclusion

The TFIIIB complex plays an important role in gene expression and regulation and is closely related to the occurrence and development of various diseases. Drug research on TFIIIB mainly focuses on inhibiting the activity of TFIIIB, reducing the binding affinity of TFIIIB to RNA, and blocking the binding of TFIIIB to DNA. With the deepening of research, TFIIIB will become a potential drug target and provide new ideas and methods for the treatment of various diseases.

Protein Name: Transcription Factor TFIIIB Complex

The "Transcription factor TFIIIB complex Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Transcription factor TFIIIB complex comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets